Gilead joins GSK, J&J in offering coronavirus vaccine options
The pharma giant is offering its experimental remdesivir in the running for the optimal vaccine candidate.
Read More
Tag: Wuhan
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
